journal article·2005-03

In vivo tissue response to resorbable silica xerogels as controlled-release materials

Shula Radin, Gehan El-Bassyouni, Edward J. Vresilovic, Evert Schepers, Paul Ducheyne

Biomaterials· Volume 26· Issue 9
Publisher page

Abstract

Biodegradable, controlled-release carrier materials with non-toxic degradation products are valuable for local delivery of biologically active molecules. Previously, it was shown that room-temperature processed silica sol-gels (or xerogels) are porous, resorbable materials that can release molecules of various sizes in a controlled, time dependent manner. Previous in vitro studies also demonstrated benefits of silica xerogels as controlled-release materials for the treatment of bone infections. Herein the tissue and cell response to xerogels is documented using a subacute implantation procedure. The tissue response was correlated to composition, surface properties, resorption rate and incorporation of the antibiotic vancomycin. Ca- and P-free and Ca- and P-containing xerogels, with and without apatite (AP) surface, were used. Xerogels were implanted either as discs in a subcutaneous site, or as granules in the iliac crest of New Zealand white rabbits. The samples with surrounding tissue were retrieved after 2 and 4 weeks of implantation. Silica xerogels implanted either as discs subcutaneously or as granules in the iliac crest showed a favorable tissue response. The granules, either with or without Ca and P content, gradually resorbed over time. The resorption was accompanied by extensive trabecular bone growth and a minimal inflammatory response. Ca- and P-containing granules with an AP-surface layer showed a slower resorption rate and more extensive new bone growth than those without AP layer. Among AP-coated granules, those with incorporated vancomycin showed the most favorable tissue response. The present in vivo data together with prior in vitro data suggest that these xerogels have potential as controlled-release materials for the treatment of bone infections and as carrier materials for a variety of other applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. Controlled release of bioactive agents from lactide/glycolide polymers
2. Biodegradable polymers for controlled drug delivery
3. Use of polymers in controlled release of active agents
4. Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation, and release characteristics10.1002/jbm.820190806 ↗
5. Controlled release using a new bioerodible polyphosphazene matrix system10.1002/jbm.820211006 ↗
6. Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H ↗
7. In vitro behavior of silica-based xerogels intended as controlled release carriers10.1111/j.1151-2916.1999.tb01861.x ↗
8. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials10.1016/S0142-9612(02)00051-0 ↗
9. Biologically active sol–gel glasses10.1016/0167-577X(90)90002-4 ↗
10. Living ceramics10.1007/BF00488377 ↗
11. Bioartificial organs 110.1023/A:1018368109784 ↗
12. In vitro release kinetics of biologically active transforming growth factor-β1 from novel porous glass carrier10.1016/S0142-9612(97)00008-2 ↗
13. Sol–gel derived carrier for the controlled release of proteins10.1016/S0142-9612(99)00066-6 ↗
14. Silica sol–gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E ↗
15. Silica sol–gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vancomycin10.1002/1097-4636(20011205)57:3<321::AID-JBM1174>3.0.CO;2-S ↗
16. Sol–gel carrier systems for controlled drug delivery10.1023/A:1008603622543 ↗
17. In vitro evaluation of sol–gel processed spray dried silica gel microspheres as carrier in controlled drug delivery10.1016/S0378-5173(00)00393-8 ↗
18. Silica xerogel carrier material for controlled release of toremifene citrate10.1016/S0378-5173(99)00403-2 ↗
20. Tissue reactions to controlled release silica xerogels carriers
21. Brinker · 1990
22. Stimulation of bone healing by transforming growth factor-beta1 released from polymeric or ceramic implants10.1002/jab.770050207 ↗
23. Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute10.1002/jor.1100110502 ↗
24. Antibiotic loaded plaster of paris pellets10.1097/00003086-198207000-00041 ↗
25. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics10.1302/0301-620X.74B4.1320622 ↗
26. Synthesis of antibiotic-loaded hydroxyapatite beads and in vitro drug release testing10.1002/jbm.820260807 ↗
27. Drug release from a novel self-setting bioactive glass bone cement containing cephalexin and its physicochemical properties10.1002/jbm.820290106 ↗
28. Biological activities of sustained polymixin B release from calcium phosphate biomaterial prepared by dynamic compaction10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T ↗
29. Antibiotic-loaded plaster of Paris implants coated with poly lactide-co-glycolide as a controlled release delivery system for the treatment of bone infections10.1007/s002640050195 ↗
30. Silicon excretion from bioactive glass implanted in rabbit bone10.1016/S0142-9612(01)00097-7 ↗
31. Bioactive glass particulate as a filler for bone lesions10.1111/j.1365-2842.1991.tb01689.x ↗
32. Thickness of fibrous capsule after implantation of hydroxyapatite in subcutaneous tissue in rats10.1002/(SICI)1097-4636(19990615)45:4<322::AID-JBM6>3.0.CO;2-2 ↗
33. Toxicology and biocompatibility of bioglasses10.1002/jbm.820150605 ↗
34. Poly(anhydride) administration in high doses in vivo10.1002/jbm.820241105 ↗
35. Poly(anhydride-co-imides)10.1016/S0142-9612(98)00019-2 ↗